BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 9049231)

  • 1. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study.
    Bruno S; Silini E; Crosignani A; Borzio F; Leandro G; Bono F; Asti M; Rossi S; Larghi A; Cerino A; Podda M; Mondelli MU
    Hepatology; 1997 Mar; 25(3):754-8. PubMed ID: 9049231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b.
    Zein NN; Poterucha JJ; Gross JB; Wiesner RH; Therneau TM; Gossard AA; Wendt NK; Mitchell PS; Germer JJ; Persing DH
    Am J Gastroenterol; 1996 Dec; 91(12):2560-2. PubMed ID: 8946986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study.
    Tanaka K; Nagao Y; Ide T; Kumashiro R; Sata M
    Int J Mol Med; 2006 May; 17(5):827-32. PubMed ID: 16596267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
    Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus genotypes in patients with hepatocellular carcinoma.
    Akkiz H; Colakoğlu S; Köksal F; Korkut H; Hafta A
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):85-8. PubMed ID: 9216790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR; Bhan AK; Zheng H; Chung RT
    Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis.
    Benvegnù L; Pontisso P; Cavalletto D; Noventa F; Chemello L; Alberti A
    Hepatology; 1997 Jan; 25(1):211-5. PubMed ID: 8985292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b.
    Kobayashi M; Akuta N; Suzuki F; Hosaka T; Sezaki H; Kobayashi M; Suzuki Y; Arase Y; Ikeda K; Watahiki S; Mineta R; Iwasaki S; Miyakawa Y; Kumada H
    J Med Virol; 2010 Jan; 82(1):41-8. PubMed ID: 19950230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
    Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus genotypes and viremia and hepatocellular carcinoma in the United States.
    Reid AE; Koziel MJ; Aiza I; Jeffers L; Reddy R; Schiff E; Lau JY; Dienstag JL; Liang TJ
    Am J Gastroenterol; 1999 Jun; 94(6):1619-26. PubMed ID: 10364034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and course of small hepatocellular carcinomas in patients with hepatitis C virus types 1 and 2.
    Toyoda H; Kumada T; Nakano S; Takeda I; Sugiyama K; Kiriyama S; Sone Y; Hisanaga Y
    J Med Virol; 2001 Feb; 63(2):120-7. PubMed ID: 11170048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
    Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS
    J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
    Peng YC; Chan CS; Chen GH
    Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study.
    Bruno S; Crosignani A; Maisonneuve P; Rossi S; Silini E; Mondelli MU
    Hepatology; 2007 Nov; 46(5):1350-6. PubMed ID: 17680653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis.
    Raimondi S; Bruno S; Mondelli MU; Maisonneuve P
    J Hepatol; 2009 Jun; 50(6):1142-54. PubMed ID: 19395111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.